EP0757573A1 - Method of electrical nerve stimulation - Google Patents

Method of electrical nerve stimulation

Info

Publication number
EP0757573A1
EP0757573A1 EP95910859A EP95910859A EP0757573A1 EP 0757573 A1 EP0757573 A1 EP 0757573A1 EP 95910859 A EP95910859 A EP 95910859A EP 95910859 A EP95910859 A EP 95910859A EP 0757573 A1 EP0757573 A1 EP 0757573A1
Authority
EP
European Patent Office
Prior art keywords
patient
electrical
applying
electrode
stimulating electrode
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP95910859A
Other languages
German (de)
French (fr)
Other versions
EP0757573A4 (en
EP0757573B1 (en
Inventor
Horst Edgar Krause
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP0757573A1 publication Critical patent/EP0757573A1/en
Publication of EP0757573A4 publication Critical patent/EP0757573A4/de
Application granted granted Critical
Publication of EP0757573B1 publication Critical patent/EP0757573B1/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/326Applying electric currents by contact electrodes alternating or intermittent currents for promoting growth of cells, e.g. bone cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/3603Control systems
    • A61N1/36031Control systems using physiological parameters for adjustment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/3603Control systems
    • A61N1/36034Control systems specified by the stimulation parameters

Definitions

  • the present invention relates to methods for healing tissues. More particularly, the present invention relates to methods and apparatus for electrical stimulation of the nerve system of a human body synchronous to a cardiac cycle or other events in the human body.
  • electrical nerve stimulators are widely used to induce the contraction of skeletal muscle groups and for the relief of pain by blocking nerve conduction.
  • electrodes are placed near specific nerves either superficially, percutaneously, or by surgical implantation.
  • the stimulation is accomplished by applying an electrical current to the electrodes.
  • the current is applied in the form of a series of pulses.
  • the duration of an individual pulse, the number of pulses in the series, the time interval of no stimulation after a stimulating pulse series, and the magnitude of the applied electrical current are, in general, variable and are adjusted by the attending physician, therapist, or patient.
  • Hotta et al. report about observations that provide some details about the mechanism behind the increase of the flow rate in the extremities in his article "Stimulation of Lumbar Sympathetic Trunk Produces Vasoconstriction of the Vasa Nervorum in the Sciatic Nerve Via o(-Adrenergic Receptors in Rats", Neuroscience Letters, 1991.
  • the unilateral electrical stimulation of the lumbar sympathetic trunk at low frequencies produced a substantial increase in the flow of blood in the vasa nervorum of the sciatic nerves in the hind legs of rats. This period of increased flow was followed by a moderate decrease of this flow in the leg on the side of stimulation while only the increase of flow was observed in the leg on the other side.
  • the present invention is a method of electrical nerve stimulation for the acceleration of tissue healing of a patient.
  • the method of the present invention includes the steps of: (1) applying a receptor electrode to an area of the body of the patient; (2) applying a stimulating electrode to another area of the body of the patient; (3) transmitting a signal from the receptor electrode to an electrocardiograph (ECG) so as to produce a representation of a cardiac cycle (ECG) of the patient; and (4) passing an electrical pulse to the stimulating electrode in timed relationship to the representation of the cardiac cycle.
  • ECG electrocardiograph
  • ECG cardiac cycle
  • the terms "electrode” and “pulse” are inclusive of the plural “electrodes” and “pulses”, respectively.
  • the cardiac cycle shows a systolic period and a diastolic period.
  • the step of passing includes passing a plurality of electrical pulses during the systolic period of the cardiac cycle in the preferred embodiment. This plurality of electrical pulses occur throughout a selected period of the cardiac cycle, such as the systolic period.
  • the step of applying the stimulating electrode includes affixing the stimulating electrode to an area of the body other than the tissue to be healed.
  • the stimulating electrode is applied so as to result in the stimulation of the vascular smooth muscles of the splanchnic circulatory system.
  • the electrical pulse is passed so as to be of sufficient energy such that the vascular smooth muscles are contracted so as to increase hydraulic resistance of at least a portion of the splanchnic circulatory system.
  • the step of applying a- receptor includes applying a plurality of receptor electrodes to the patient.
  • the step of transmitting includes connecting the receptor electrodes to an electrocardiograph, amplifying an electrical signal of the heart so as to produce the representation of the cardiac cycle, and creating a graphical illustration of the cardiac cycle.
  • a triggering device is connected to the ECG and to the stimulator.
  • the triggering device is programmed so as to pass the electrical pulse repeatedly.
  • the stimulator serves to transmit stimulating pulses to the patient via the stimulating electrode.
  • the programming of the stimulator can include adjusting the magnitude of the voltage or current of the electrical pulse.
  • the programming can include adjusting the length of time of the pulse or the amount of time between consecutive pulses.
  • the step of programming can further include adjusting the amplitude or frequency modulation of a plurality of electrical pulses within a single pulse train.
  • FIGURE 1 is a schematic illustration of the method of the present invention.
  • FIGURE 2 is a multiple graphical illustration of the method of the present invention in relation to aortic pressure and the ECG graph.
  • FIGURE 1 there is shown at 10, the system of the present invention for the electrical stimulation for the acceleration of tissue healing of the patient 12.
  • the system 10 includes the ECG 14, a trigger device 16, and a stimulator 18. Each of these elements are interactive so as to provide the required electrically stimulating effect for the purpose of healing the tissue of patient 12.
  • the receptor electrodes 20, 22, and 24 are applied to the patient 12.
  • the purpose of the electrodes 20, 22, and 24 is to transmit electrical signals generated by the heart and to communicate such signals to the electrocardiograph via the connecting cables.
  • a single receptor electrode could be used.
  • a plurality of such electrodes are used so as to provide a representative reading to the electrocardiograph.
  • the electrodes 20, 22, and 24 sense the potential of the electrical currents generated by the heart and communicate them to the electrocardiograph 14.
  • the electrocardiograph amplifies these potentials greatly. These potentials will vary in magnitude in a typical fashion during the course of a cardiac cycle.
  • FIGURE 2 illustrates such an ECG, together with the simultaneously occurring variation of the aortic pressure during the course of the same cardiac cycle.
  • ECG electrocardiogram
  • FIGURE 2 illustrates such an ECG, together with the simultaneously occurring variation of the aortic pressure during the course of the same cardiac cycle.
  • the electrocardiogram is composed of three very distinct events. These events are the P wave, the so-called QRS complex, and the T wave.
  • the P wave occurs at the beginning of each contraction of the atria.
  • the QRS complex occurs at the beginning of each contraction of the ventricles.
  • the T wave occurs as the ventricles recover electrically and prepare for the next contraction.
  • the electrocardiograph 14 provides the ECG as an electrical input to the trigger component 16. It is evident from an inspection of the ECG in FIGURE 2 that considerable and characteristic variations occur that are typical for certain portions and instances within one cardiac cycle. For example, the peak voltages of all three above-mentioned sections (P wave, QRS complex, T wave) are significantly different.
  • the slope of the QRS complex differs considerably from that of the P wave or the T wave.
  • the slopes, as well as the voltages assume both positive and negative values during the course of a cardiac cycle. Therefore, the peak of a wave, the combination of a voltage and the simultaneously existing rate of its change (slope), or only a voltage, should be characteristic for most instances during these three segments and can therefore be used to identify the instantaneous status of the ventricles within a cardiac cycle.
  • the possibility of ambiguity of identification can be reduced by also considering a third variable, besides instantaneous voltage and slope.
  • Such a variable could be the time interval between the occurrence of a very distinct and unique point, such as the greatest negative voltage preceded by a sharp negative slope followed by a sharp positive slope (also designated as the Q instant), and the voltage and slope at the instant of recording.
  • Various algorithms using such variables as inputs, as well as sophisticated mathematical transforms, filtering, correlation, and signal identification methods, can be utilized to numerically correlate pertinent instances as to their position within the period of one cardiac cycle.
  • the trigger device 16 is a processor which will receive the ECG 14 as input and process it in the manner described above so as to activate the stimulator 18 at the desired instance and for the desired period of time.
  • the trigger device 16 can also incorporate several channels and outputs so as to activate a multitude of devices at individual instances and for individual intervals.
  • SUBSUME and 28 are applied to the body of the patient 12.
  • the stimulating electrodes 26 and 28 are positioned on certain areas of the body of the patient 12 other than the tissue to be healed.
  • the stimulator electrodes 26 and 28 receive their electrical pulse from the stimulator 18.
  • Trigger device 16 can also transmit signals to additional stimulators or other devices.
  • the cardiac cycle will have a systolic period and a diastolic period.
  • the stimulator 18 will pass electrical pulses during the systole period of the cardiac cycle.
  • the electrical stimulation is graphically illustrated in relation to the systolic period, it can also be seen in FIGURE 2 that a plurality of electrical impulses occur throughout an entire systolic period.
  • the triggering device 16 is programmed so as to pass the triggering pulse repeatedly at identical instances during sequential cardiac cycles.
  • the stimulating electrodes 26 and 28 are placed over or on selected nerves and connected to the stimulator 18.
  • a preprogrammed personalized sequence of electrical impulses is delivered from the stimulator 18 to the nerve simultaneously with the onset of cardiac systole. The electrical impulses will continue to be delivered throughout this period.
  • the electrical stimulus is structured such that the vascular smooth muscles of the splanchnic circulatory system are innervated, contract, and increase the hydraulic resistance of this part of the systemic circulation.
  • the amount of blood flowing into diseased extremities is increased.
  • the systolic peak pressure is increased in the diseased extremities because the elevated splanchnic hydraulic input resistance reflects a greater portion of the pulsatile pressure and flow components back into the remaining part of the systemic circulatory system. This increases the pulsatile energy in that part by as much as sixty percent.
  • the elevation of the pulse pressure drives more blood through pathologically underperfused blood vessels, generates collateral vessels and, by delivering oxygen and nutrients, accelerates and enables the healing process.
  • the endothelial cells release vasodilatory substances, such as prostacyclin, while being mechanically stimulated by blood pressure variations. Therefore, the increase in the flow of blood is further advanced by the restoration and elevation of pressure pulsations and the resulting prostacyclin release in and around tissues and organs with obliterative vascular condition.
  • the output of the trigger device allows the medical personnel to enter one, two, or three variables (or a code number), or to place an indicator within a display of the ECG at a point at which they choose to have the trigger device 16 activate the stimulator 18. It also allows the medical personnel to select a second point or time interval at which they choose to terminate the stimulation until the same sequence is automatically resumed during the following cardiac cycles.
  • the triggering of the stimulator 18 at the selected instances and in synchrony with the ECG or any other internal or external event constitutes an improvement over prior methods of treatment and also introduces new possibilities of treatment.
  • the stimulator 18 upon triggering, provides a structured stimulus to a selected nerve or bundles of nerves via electrodes which are located on the patient's body surface, or are placed percutaneously, or by surgical implantation. Both the location of the electrodes and the structure of the stimulus are specific as to the pathological condition of the patient.
  • the stimulator therefore, is equipped for producing various types of stimulation structures in order to treat a variety of pathological conditions. Therefore, the variables that are adjustable by the medical personnel include the shape of the stimulating pulses, the magnitude of their current or voltage, the interval of time of an individual pulse, the interval of time between two consecutive pulses, the number of such pulses within a train
  • SUBSTtTUTE SHEET (RUIE 26 of pulses, the amplitude and/or frequency modulation of the pulses within one train, and the time interval between trains of pulses. Since the structure of stimulation is often specific for the pathological condition and/or the patient, the stimulator 18 is equipped with a computer so that, among other functions, the optimal structure, after being determined by the clinic, can be programmed into the stimulator 18. In such a situation, the patient can then use the stimulator safely on his or her own, while performing most of the daily routines.
  • the present invention is essentially an electrical nerve stimulation system that incorporates an electrocardiograph in communication with a patient and in communication with an electric signal identifying device.
  • This device identifies select points on the electrocardiogram and provides a triggering impulse which activates an electrical nerve stimulator in timed relation with the heart or other intracorporeal or extracorporeal events.
  • the stimulator provides a stimulus which is structured to elevate the arterial blood pressure pulse and this effect is maximized by the system's capability to stimulate synchronously with and during the cardiac systole.
  • the flow of blood through pathologically underperfused tissues is increased, collateralization is proliferated, and healing of wounds, ulcers, and neuropathic conditions is accelerated and made possible in previously unresponsive cases.
  • the present invention is also an electrical nerve stimulation system which can promote healing in relation to an extracorporeal or an internal event relative to the patient.
  • the receptor electrode is applied to a source indicative of the extracorporeal or internal event.
  • the processor is then used to produce a representation of such event. Electrical pulses are then passed to the stimulating electrodes in timed relationship to the representation of the event.

Abstract

A method of electrical nerve stimulation for acceleration of tissue healing of a patient including the steps of applying a receptor electrode (20) (22) (24) to an area of a body of the patient, applying a stimulating electrode (26) (28) to another area of the body of the patient, transmitting a signal from the receptor electrode (20) (22) (24) to an ECG (14) so as to produce a representation of a cardiac cycle of the patient, and passing an electrical pulse to the stimulating electrode (26) (28) in timed relationship to the representation of the cardiac cycle. A plurality of electrical pulses are passed during each systole period of the cardiac cycle. The stimulating electrode (26) (28) is affixed to an area of the body. A triggering device (16) is connected to the ECG (14) and to the stimulating electrode (26) (28). The triggering device (16) is programmed so as to pass the electrical pulse repeatedly during identical periods during sequential cardiac cycles.

Description

METHOD OF ELECTRICAL NERVE STIMULATION
TECHNICAL FIELD
The present invention relates to methods for healing tissues. More particularly, the present invention relates to methods and apparatus for electrical stimulation of the nerve system of a human body synchronous to a cardiac cycle or other events in the human body.
BACKGROUND ART
Wounds, skin ulcers and sores of various types and origins require a long time to heal. This healing time results in an equally long period of suffering and a corresponding increase in the cost of medical care. Often, these conditions do not respond to conventional treatment and sometimes lead to a permanent affliction. In some cases, the condition progresses until it becomes necessary to amputate the limb, as in the case of over 35,000 diabetics annually. The danger of permanent affliction or even death is present if response to treatment is poor and gangrenous infection sets in.
Various methods of electrical nerve stimulation are in use for various therapeutic purposes, including the relief of otherwise intractable pain. In particular, electrical nerve stimulators are widely used to induce the contraction of skeletal muscle groups and for the relief of pain by blocking nerve conduction. To accomplish this, electrodes are placed near specific nerves either superficially, percutaneously, or by surgical implantation. The stimulation is accomplished by applying an electrical current to the electrodes. The current is applied in the form of a series of pulses. The duration of an individual pulse, the number of pulses in the series, the time interval of no stimulation after a stimulating pulse series, and the magnitude of the applied electrical current are, in general, variable and are adjusted by the attending physician, therapist, or patient.
. In the past, various articles have been written concerning techniques for the electrical stimulation of nerve centers for the purposes of treating the human body. These articles have observed increased blood flow in ischemic areas, the elimination of Raynaud disease symptoms, and an accelerated healing of ulcers of various etiology and ulcers that had not previously responded to conventional treatment. For example, the article of Cook et al., "Vascular Disease of Extremities", New York State Journal of Medicine, March 1976, describes the electrical stimulation of the spinal cord and posterior roots. This stimulation was carried out in nine patients with varying degrees of vascular insufficiency in a limb. The electrical stimulation resulted in a striking relief of pain. The infarcted tissue was not restored, but healing was promoted. The results were geared to antidromic stimulation of C fibers in dorsal roots. In this article and in other articles, changes in circulation beyond that obtained with previous regional sympathectomy were observed and identified as the reasons for initiating and promoting healing of wounds and ulcers.
The article by Dooley et al., "Modification of Blood Flow to the Extremities by Electrical Stimulation of the Nervous System," South Medical Journal, 1976, described the sixteen patients who had electrical stimulation applied to various portions of the nervous system. Seven of the patients had transcutaneous stimulation applied over the cervical or thoracic spinal cord, peripheral nerves, or lower lumbar region. Eight patients had electrical stimulators implanted over the spinal cord in attempts to relieve intractable pain or some of the symptoms of multiple sclerosis. Another patient had electrical stimulators implanted over the C-6 dorsal roots for small artery disease. The electrical stimulation resulted in significant arterial dilatation and corresponding flow increases. Electrical stimulation applied to the ulnar nerves did not cause arterial dilatation.
The article by Meglio et al., "Pain Control and Improvement of Peripheral Blood Flow Following Epidural Spinal Cord Stimulation, " Journal of Neurosurgery, 1981, taught the use of epidural spinal cord stimulation for the relief of chronic pain in arteriosclerotic patient. The healing of trophic ulcers was also observed. Hemodynamic studies showed an increase of peripheral blood flow following such stimulation.
The article by B. Kaada, "Promoted Healing of Chronic Ulceration By Transcutaneous Nerve Stimulation," VASA, 1983, and by B. Kaada, "Vasodilation Induced By Transcutaneous Nerve Stimulation In Peripheral Ischemia (Raynaud's Phenomenon and Diabetic Polyneuropathy), " European Heart Journal 1982, indicated that marked and prolonged cutaneous vasodilation is produced in patients with Raynaud's Disease and diabetic polyneuropathy in response to distant, low frequency and, in this case, nontraumatic transcutaneous nerve stimulation. This stimulation promoted healing of chronic ulceration of various etiology.
The article by Tallis et al., "Spinal Cord Stimulation In Peripheral Vascular Disease, " Journal of Neurology, Neurosurgery, and Psychiatry, 1983, suggested the use of spinal cord stimulation for the treatment of severe intractable symptoms of arterial disease. The electrical stimulation resulted in small increases in cutaneous and muscle blood flow. The improvements were maintained as long as spinal cord stimulation was continued.
In the article by Augustinsson et al., "Epidural Electrical Stimulation in Severe Limb Ischemia, " Annals of Surgery, 1985, it was suggested that epidural spinal electrical stimulation could improve peripheral circulation in the cases of ischemic pain, skin ulcerations, and gangrene. It was found that this electrical stimulation was very promising in severe limb ischemia where reconstructive surgery was impossible or had failed. Approximately fifty percent of previously unresponsive ulcers could be healed. Only 38% of the treated patients had an amputation as compared to 90% in a comparable group of unstimulated patients.
Hotta et al. report about observations that provide some details about the mechanism behind the increase of the flow rate in the extremities in his article "Stimulation of Lumbar Sympathetic Trunk Produces Vasoconstriction of the Vasa Nervorum in the Sciatic Nerve Via o(-Adrenergic Receptors in Rats", Neuroscience Letters, 1991. The unilateral electrical stimulation of the lumbar sympathetic trunk at low frequencies produced a substantial increase in the flow of blood in the vasa nervorum of the sciatic nerves in the hind legs of rats. This period of increased flow was followed by a moderate decrease of this flow in the leg on the side of stimulation while only the increase of flow was observed in the leg on the other side. The increase of flow, and only this increase, could still be observed in both legs after local sympathetic denervation. The mean arterial pressure remained elevated throughout the stimulation period in every one of the above experimental conditions. The observed increase of flow in the extremities was a passive response due to a central systemic constriction and not to peripherally located nervous responses. Thus the flow rate in the vasa nervorum, or other compromised vascular beds, can be maximized by selecting the proper frequency of stimulation, duration of stimulation, and should be further augmented by synchronisation with systolic pressure peaks.
In his extensive publication "Circulatory Response to Stimulation of Somatic Afferents", Acta. Physiol. Scandi, 1962, Johansson confirms the interpretation by Hotta by observing substantial increases of the resistance to flow, and concomitant arterial pressure rise, in the kidneys in response to afferent electrical stimulation of peripheral somatic nerves. The same observation was made by other authors (e.g., Olov Celander, "The Range of Control Exercised by the Sympathetic Adrenal System", Acta. Physiol. Scandi, 1954) for other internal organs including the observation of a frequency dependent degree of resistance elevation.
As can be seen, in the past, most physicians and manufacturers have viewed nerve stimulation as strictly nervous events in the 'afflicted area. These physicians and manufacturers have generally ignored the promotion of healing through increased circulation produced by "synchronized nerve stimulation" .
It is an object of the present invention to provide a method for the acceleration of tissue healing.
It is another object of the present invention to provide a method for increasing blood flow through deprived tissues.
It is a further object of the present invention to provide a method that correlates electrical stimulation of nerves to the action of the heart or other internal or extracorporeal events.
These and other objects and advantages of the present invention will become apparent from a reading of the attached specification and appended claims.
SUMMARY OF THE INVENTION
The present invention is a method of electrical nerve stimulation for the acceleration of tissue healing of a patient. The method of the present invention includes the steps of: (1) applying a receptor electrode to an area of the body of the patient; (2) applying a stimulating electrode to another area of the body of the patient; (3) transmitting a signal from the receptor electrode to an electrocardiograph (ECG) so as to produce a representation of a cardiac cycle (ECG) of the patient; and (4) passing an electrical pulse to the stimulating electrode in timed relationship to the representation of the cardiac cycle. As used herein, the terms "electrode" and "pulse" are inclusive of the plural "electrodes" and "pulses", respectively.
In particular, the cardiac cycle shows a systolic period and a diastolic period. The step of passing includes passing a plurality of electrical pulses during the systolic period of the cardiac cycle in the preferred embodiment. This plurality of electrical pulses occur throughout a selected period of the cardiac cycle, such as the systolic period.
The step of applying the stimulating electrode includes affixing the stimulating electrode to an area of the body other than the tissue to be healed. In particular, in the preferred embodiment of the present invention, the stimulating electrode is applied so as to result in the stimulation of the vascular smooth muscles of the splanchnic circulatory system. The electrical pulse is passed so as to be of sufficient energy such that the vascular smooth muscles are contracted so as to increase hydraulic resistance of at least a portion of the splanchnic circulatory system.
In the present invention, the step of applying a- receptor includes applying a plurality of receptor electrodes to the patient. The step of transmitting includes connecting the receptor electrodes to an electrocardiograph, amplifying an electrical signal of the heart so as to produce the representation of the cardiac cycle, and creating a graphical illustration of the cardiac cycle.
In the method of the present invention, a triggering device is connected to the ECG and to the stimulator. The triggering device is programmed so as to pass the electrical pulse repeatedly. The stimulator serves to transmit stimulating pulses to the patient via the stimulating electrode. The programming of the stimulator can include adjusting the magnitude of the voltage or current of the electrical pulse. The programming can include adjusting the length of time of the pulse or the amount of time between consecutive pulses. The step of programming can further include adjusting the amplitude or frequency modulation of a plurality of electrical pulses within a single pulse train.
BRIEF DESCRIPTION OF THE DRAWINGS
FIGURE 1 is a schematic illustration of the method of the present invention.
FIGURE 2 is a multiple graphical illustration of the method of the present invention in relation to aortic pressure and the ECG graph.
DETAILED DESCRIPTION OF THE INVENTION
Referring to FIGURE 1, there is shown at 10, the system of the present invention for the electrical stimulation for the acceleration of tissue healing of the patient 12. The system 10 includes the ECG 14, a trigger device 16, and a stimulator 18. Each of these elements are interactive so as to provide the required electrically stimulating effect for the purpose of healing the tissue of patient 12.
Initially, the receptor electrodes 20, 22, and 24 are applied to the patient 12. The purpose of the electrodes 20, 22, and 24 is to transmit electrical signals generated by the heart and to communicate such signals to the electrocardiograph via the connecting cables. Within the scope of the present invention, a single receptor electrode could be used. However, in the preferred embodiment of the present invention, a plurality of such electrodes are used so as to provide a representative reading to the electrocardiograph.
The electrodes 20, 22, and 24 sense the potential of the electrical currents generated by the heart and communicate them to the electrocardiograph 14. The electrocardiograph amplifies these potentials greatly. These potentials will vary in magnitude in a typical fashion during the course of a cardiac cycle.
The electrocardiograph will produce a graphic recording of the cardiac cycle in an electrocardiogram (ECG). FIGURE 2 illustrates such an ECG, together with the simultaneously occurring variation of the aortic pressure during the course of the same cardiac cycle. With reference to FIGURE 2, it can be seen that the electrocardiogram is composed of three very distinct events. These events are the P wave, the so-called QRS complex, and the T wave. The P wave occurs at the beginning of each contraction of the atria. The QRS complex occurs at the beginning of each contraction of the ventricles. The T wave occurs as the ventricles recover electrically and prepare for the next contraction. It is, therefore, apparent that these distinct features of the ECG are uniquely related to the pumping action of the heart and, as a consequence, uniquely related to the variations of the blood pressure and blood flow during the course of one cardiac cycle. In FIGURE 2, it can be seen that the systolic period corresponds generally to the period between the end of the QRS complex period and the peak of the T wave. In the preferred embodiment of the present invention, the electrocardiograph 14 provides the ECG as an electrical input to the trigger component 16. It is evident from an inspection of the ECG in FIGURE 2 that considerable and characteristic variations occur that are typical for certain portions and instances within one cardiac cycle. For example, the peak voltages of all three above-mentioned sections (P wave, QRS complex, T wave) are significantly different. Secondly, the slope of the QRS complex, for instance, differs considerably from that of the P wave or the T wave. The slopes, as well as the voltages, assume both positive and negative values during the course of a cardiac cycle. Therefore, the peak of a wave, the combination of a voltage and the simultaneously existing rate of its change (slope), or only a voltage, should be characteristic for most instances during these three segments and can therefore be used to identify the instantaneous status of the ventricles within a cardiac cycle. The possibility of ambiguity of identification can be reduced by also considering a third variable, besides instantaneous voltage and slope. Such a variable could be the time interval between the occurrence of a very distinct and unique point, such as the greatest negative voltage preceded by a sharp negative slope followed by a sharp positive slope (also designated as the Q instant), and the voltage and slope at the instant of recording. Various algorithms, using such variables as inputs, as well as sophisticated mathematical transforms, filtering, correlation, and signal identification methods, can be utilized to numerically correlate pertinent instances as to their position within the period of one cardiac cycle.
The trigger device 16 is a processor which will receive the ECG 14 as input and process it in the manner described above so as to activate the stimulator 18 at the desired instance and for the desired period of time. The trigger device 16 can also incorporate several channels and outputs so as to activate a multitude of devices at individual instances and for individual intervals. In the method of the present invention a plurality of stimulating electrodes 26
SUBSUME and 28 are applied to the body of the patient 12. Within the concept of the present invention, the stimulating electrodes 26 and 28 are positioned on certain areas of the body of the patient 12 other than the tissue to be healed. The stimulator electrodes 26 and 28 receive their electrical pulse from the stimulator 18. Trigger device 16 can also transmit signals to additional stimulators or other devices.
In the present invention, the cardiac cycle will have a systolic period and a diastolic period. The stimulator 18 will pass electrical pulses during the systole period of the cardiac cycle. As can be seen in FIGURE 2, the electrical stimulation is graphically illustrated in relation to the systolic period, it can also be seen in FIGURE 2 that a plurality of electrical impulses occur throughout an entire systolic period. The triggering device 16 is programmed so as to pass the triggering pulse repeatedly at identical instances during sequential cardiac cycles.
In the specific embodiment of the present invention, the stimulating electrodes 26 and 28 are placed over or on selected nerves and connected to the stimulator 18. Upon activation of the system 10, a preprogrammed personalized sequence of electrical impulses is delivered from the stimulator 18 to the nerve simultaneously with the onset of cardiac systole. The electrical impulses will continue to be delivered throughout this period.
The electrical stimulus is structured such that the vascular smooth muscles of the splanchnic circulatory system are innervated, contract, and increase the hydraulic resistance of this part of the systemic circulation. As a consequence, the amount of blood flowing into diseased extremities is increased. In particular, the systolic peak pressure is increased in the diseased extremities because the elevated splanchnic hydraulic input resistance reflects a greater portion of the pulsatile pressure and flow components back into the remaining part of the systemic circulatory system. This increases the pulsatile energy in that part by as much as sixty percent. The elevation of the pulse pressure drives more blood through pathologically underperfused blood vessels, generates collateral vessels and, by delivering oxygen and nutrients, accelerates and enables the healing process.
The endothelial cells release vasodilatory substances, such as prostacyclin, while being mechanically stimulated by blood pressure variations. Therefore, the increase in the flow of blood is further advanced by the restoration and elevation of pressure pulsations and the resulting prostacyclin release in and around tissues and organs with obliterative vascular condition.
This operation of the present invention constitutes but one preferred example of it. The output of the trigger device allows the medical personnel to enter one, two, or three variables (or a code number), or to place an indicator within a display of the ECG at a point at which they choose to have the trigger device 16 activate the stimulator 18. It also allows the medical personnel to select a second point or time interval at which they choose to terminate the stimulation until the same sequence is automatically resumed during the following cardiac cycles. The triggering of the stimulator 18 at the selected instances and in synchrony with the ECG or any other internal or external event constitutes an improvement over prior methods of treatment and also introduces new possibilities of treatment.
The stimulator 18, upon triggering, provides a structured stimulus to a selected nerve or bundles of nerves via electrodes which are located on the patient's body surface, or are placed percutaneously, or by surgical implantation. Both the location of the electrodes and the structure of the stimulus are specific as to the pathological condition of the patient. The stimulator, therefore, is equipped for producing various types of stimulation structures in order to treat a variety of pathological conditions. Therefore, the variables that are adjustable by the medical personnel include the shape of the stimulating pulses, the magnitude of their current or voltage, the interval of time of an individual pulse, the interval of time between two consecutive pulses, the number of such pulses within a train
SUBSTtTUTE SHEET (RUIE 26 of pulses, the amplitude and/or frequency modulation of the pulses within one train, and the time interval between trains of pulses. Since the structure of stimulation is often specific for the pathological condition and/or the patient, the stimulator 18 is equipped with a computer so that, among other functions, the optimal structure, after being determined by the clinic, can be programmed into the stimulator 18. In such a situation, the patient can then use the stimulator safely on his or her own, while performing most of the daily routines.
The present invention is essentially an electrical nerve stimulation system that incorporates an electrocardiograph in communication with a patient and in communication with an electric signal identifying device. This device identifies select points on the electrocardiogram and provides a triggering impulse which activates an electrical nerve stimulator in timed relation with the heart or other intracorporeal or extracorporeal events. The stimulator provides a stimulus which is structured to elevate the arterial blood pressure pulse and this effect is maximized by the system's capability to stimulate synchronously with and during the cardiac systole. Thus, the flow of blood through pathologically underperfused tissues is increased, collateralization is proliferated, and healing of wounds, ulcers, and neuropathic conditions is accelerated and made possible in previously unresponsive cases.
The present invention is also an electrical nerve stimulation system which can promote healing in relation to an extracorporeal or an internal event relative to the patient. In this configuration, the receptor electrode is applied to a source indicative of the extracorporeal or internal event. The processor is then used to produce a representation of such event. Electrical pulses are then passed to the stimulating electrodes in timed relationship to the representation of the event. ' '
The foregoing disclosure and description of the invention is illustrative and explanatory thereof, various changes in the steps of the described method may be made within the scope of the appended claims without departing from the true spirit of the invention. The present invention should only be limited by the following claims and their legal equivalents.

Claims

CLAIMSI CLAIM:
1. A method of electrical nerve stimulation for acceleration of tissue healing of a patient comprising the steps of: applying a receptor electrode to an area of a body of the patient; applying a stimulating electrode to another area of the body of the patient; transmitting a signal from said receptor electrode to a monitor so as to produce a representation of a physiological cycle of the patient; and passing an electrical pulse to said stimulating electrode in timed relationship to said representation of said physiological cycle.
2. The method of Claim 1, said physiological cycle being a cardiac cycle having a systolic period and a diastolic period, said step of passing comprising: passing a plurality of electrical pulses during said systolic period of said cardiac cycle.
3. The method of Claim 2, said plurality of said electrical pulses occurring throughout an entire systolic period.
4. The method of Claim 1, said step of applying a stimulating electrode comprising: affixing said stimulating electrode to an area of the body other than the tissue to be healed.
5. The method of Claim 4, said step of applying a stimulating electrode comprising: affixing said stimulating electrode adjacent to a nerve suitable for stimulating vascular smooth muscles of the splanchnic circulatory system.
6. The method of Claim 5, said step of passing an electrical pulse comprising: passing an electrical pulse to said nerve of sufficient energy such that said vascular smooth muscles are contracted so as to increase hydraulic resistance of a portion of the splanchnic circulatory system.
7. The method of Claim 2, said step of applying a receptor electrode comprising: applying a plurality of receptor electrodes to the patient.
8. The method of Claim 7, said step of transmitting comprising the steps of: connecting said receptor electrodes to an electrocardiograph; amplifying an electrical signal of the heart so as to produce said representation of the cardiac cycle; and creating a graphical illustration of a cardiac cycle.
9. The method of Claim 1, further comprising the steps of: connecting a triggering device to an ECG and to a stimulator, said stimulator connected to said stimulating electrodes; and programming said triggering device so as to pass a pulse repeatedly during identical instances during sequential cardiac cycles to said stimulator, said stimulator for passing an electrical signal to said stimulating electrode.
10. The method of Claim 9, said step of programming comprising: adjusting a magnitude of a voltage or current of said electrical pulse.
SUBJ
11. The method of Claim 9, said step of programming comprising: adjusting a length of time of said pulse or between consecutive pulses.
12. The method of Claim 9, said step of programming comprising: adjusting an amplitude or frequency modulation of a plurality of electrical pulses within a train.
13. The method of Claim 1, said step of applying a stimulating electrode comprising: implanting said stimulating electrode subcutaneously into said another area.
14. A method of electrical nerve stimulation for acceleration of tissue healing of a patient comprising the steps of: affixing a stimulating electrode adjacent to a nerve suitable for stimulating vascular smooth muscles of the splanchnic circulatory system of the patient; applying electrical pulses to said stimulating electrode so as to contract said vascular smooth muscles; and repeating said electrical pulses over a desired period of time.
15. The method of Claim 14, further comprising the step of: monitoring a cardiac cycle of the patient so as to determine a systole period of said cardiac cycle, said step of applying being during said systole period.
16. The method of Claim 15, said step of monitoring comprising: applying a receptor electrode to the patient; and transmitting a signal from said receptor electrode to an ECG so as to produce a representation of said cardiac cycle of the patient.
17. The method of Claim 16, said step of applying comprising: connecting said ECG to a triggering device; and programming said triggering device so as to pass said electrical pulse during said systole period of said cardiac cycle.
18. The method of Claim 14, said vascular smooth muscles not being the tissue to be healed.
19. The method of Claim 17, said step of repeating comprising: applying said electrical pulse only during said systole period, said electrical pulse being a plurality of pulses applied during each systole period, said plurality of pulses applied during sequential systole periods.
20. A method of electrical nerve stimulation for acceleration of tissue healing of a patient comprising the steps of: applying a receptor electrode to a source indicative of an extracorporeal or internal event relative to the patient; applying a stimulating electrode to a desired area of a body of the patient; transmitting a signal from said receptor electrode to a processor so as to produce a representation of said extracorporeal or internal event; and passing electrical pulses to said stimulating electrode in timed relationship to said representation.
EP95910859A 1993-12-27 1994-12-27 Apparatus for electrical nerve stimulation Expired - Lifetime EP0757573B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US173777 1980-07-30
US08/173,777 US5458626A (en) 1993-12-27 1993-12-27 Method of electrical nerve stimulation for acceleration of tissue healing
PCT/US1994/015000 WO1995017921A1 (en) 1993-12-27 1994-12-27 Method of electrical nerve stimulation

Publications (3)

Publication Number Publication Date
EP0757573A1 true EP0757573A1 (en) 1997-02-12
EP0757573A4 EP0757573A4 (en) 1997-03-26
EP0757573B1 EP0757573B1 (en) 2006-03-15

Family

ID=22633443

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95910859A Expired - Lifetime EP0757573B1 (en) 1993-12-27 1994-12-27 Apparatus for electrical nerve stimulation

Country Status (5)

Country Link
US (1) US5458626A (en)
EP (1) EP0757573B1 (en)
AU (1) AU1866795A (en)
DE (1) DE69434666T2 (en)
WO (1) WO1995017921A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006079484A1 (en) 2005-01-26 2006-08-03 Cerbomed Gmbh Device for the transdermal stimulation of a nerve of the human body
DE102011009528A1 (en) 2011-01-26 2012-07-26 Cerbomed Gmbh Device for transcutaneous stimulation of a nerve of the human body

Families Citing this family (130)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19651600A1 (en) * 1996-12-11 1998-06-18 Bavaria Patente & Lizenzen Device for stimulating a muscle or muscle groups
US7799337B2 (en) 1997-07-21 2010-09-21 Levin Bruce H Method for directed intranasal administration of a composition
US6058331A (en) * 1998-04-27 2000-05-02 Medtronic, Inc. Apparatus and method for treating peripheral vascular disease and organ ischemia by electrical stimulation with closed loop feedback control
CA2331532A1 (en) * 1998-05-08 1999-11-18 Genetronics, Inc. Electrically induced vessel vasodilation
US7599736B2 (en) * 2001-07-23 2009-10-06 Dilorenzo Biomedical, Llc Method and apparatus for neuromodulation and physiologic modulation for the treatment of metabolic and neuropsychiatric disease
US20050137644A1 (en) * 1998-10-26 2005-06-23 Boveja Birinder R. Method and system for vagal blocking and/or vagal stimulation to provide therapy for obesity and other gastrointestinal disorders
US6450942B1 (en) 1999-08-20 2002-09-17 Cardiorest International Ltd. Method for reducing heart loads in mammals
US6308102B1 (en) 1999-09-29 2001-10-23 Stimsoft, Inc. Patient interactive neurostimulation system and method
US6654642B2 (en) * 1999-09-29 2003-11-25 Medtronic, Inc. Patient interactive neurostimulation system and method
US6850801B2 (en) 2001-09-26 2005-02-01 Cvrx, Inc. Mapping methods for cardiovascular reflex control devices
US6522926B1 (en) 2000-09-27 2003-02-18 Cvrx, Inc. Devices and methods for cardiovascular reflex control
US7158832B2 (en) 2000-09-27 2007-01-02 Cvrx, Inc. Electrode designs and methods of use for cardiovascular reflex control devices
US7623926B2 (en) 2000-09-27 2009-11-24 Cvrx, Inc. Stimulus regimens for cardiovascular reflex control
US6985774B2 (en) 2000-09-27 2006-01-10 Cvrx, Inc. Stimulus regimens for cardiovascular reflex control
US7840271B2 (en) 2000-09-27 2010-11-23 Cvrx, Inc. Stimulus regimens for cardiovascular reflex control
US7499742B2 (en) 2001-09-26 2009-03-03 Cvrx, Inc. Electrode structures and methods for their use in cardiovascular reflex control
US7616997B2 (en) 2000-09-27 2009-11-10 Kieval Robert S Devices and methods for cardiovascular reflex control via coupled electrodes
US8086314B1 (en) 2000-09-27 2011-12-27 Cvrx, Inc. Devices and methods for cardiovascular reflex control
US7151914B2 (en) * 2001-08-21 2006-12-19 Medtronic, Inc. Transmitter system for wireless communication with implanted devices
JP3535855B2 (en) * 2001-09-05 2004-06-07 Necエレクトロニクス株式会社 Scan flip-flop and semiconductor integrated circuit device
US7010353B2 (en) * 2002-01-07 2006-03-07 Ebi, L.P. Non-invasive capacitively coupled electrical stimulation device for treatment of soft tissue wounds
US7689276B2 (en) * 2002-09-13 2010-03-30 Leptos Biomedical, Inc. Dynamic nerve stimulation for treatment of disorders
US7239912B2 (en) 2002-03-22 2007-07-03 Leptos Biomedical, Inc. Electric modulation of sympathetic nervous system
US7551964B2 (en) * 2002-03-22 2009-06-23 Leptos Biomedical, Inc. Splanchnic nerve stimulation for treatment of obesity
US7689277B2 (en) * 2002-03-22 2010-03-30 Leptos Biomedical, Inc. Neural stimulation for treatment of metabolic syndrome and type 2 diabetes
US7236822B2 (en) * 2002-03-22 2007-06-26 Leptos Biomedical, Inc. Wireless electric modulation of sympathetic nervous system
US7702386B2 (en) * 2002-03-22 2010-04-20 Leptos Biomedical, Inc. Nerve stimulation for treatment of obesity, metabolic syndrome, and Type 2 diabetes
US20090259279A1 (en) * 2002-03-22 2009-10-15 Dobak Iii John D Splanchnic nerve stimulation for treatment of obesity
US7937145B2 (en) * 2002-03-22 2011-05-03 Advanced Neuromodulation Systems, Inc. Dynamic nerve stimulation employing frequency modulation
US8774913B2 (en) 2002-04-08 2014-07-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for intravasculary-induced neuromodulation
US7756583B2 (en) 2002-04-08 2010-07-13 Ardian, Inc. Methods and apparatus for intravascularly-induced neuromodulation
US8150519B2 (en) 2002-04-08 2012-04-03 Ardian, Inc. Methods and apparatus for bilateral renal neuromodulation
US6978174B2 (en) 2002-04-08 2005-12-20 Ardian, Inc. Methods and devices for renal nerve blocking
US8347891B2 (en) 2002-04-08 2013-01-08 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US8145317B2 (en) 2002-04-08 2012-03-27 Ardian, Inc. Methods for renal neuromodulation
US20140018880A1 (en) 2002-04-08 2014-01-16 Medtronic Ardian Luxembourg S.A.R.L. Methods for monopolar renal neuromodulation
US7162303B2 (en) 2002-04-08 2007-01-09 Ardian, Inc. Renal nerve stimulation method and apparatus for treatment of patients
US7620451B2 (en) 2005-12-29 2009-11-17 Ardian, Inc. Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
US9308044B2 (en) 2002-04-08 2016-04-12 Medtronic Ardian Luxembourg S.A.R.L. Methods for therapeutic renal neuromodulation
US8145316B2 (en) 2002-04-08 2012-03-27 Ardian, Inc. Methods and apparatus for renal neuromodulation
US20070135875A1 (en) 2002-04-08 2007-06-14 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US7653438B2 (en) 2002-04-08 2010-01-26 Ardian, Inc. Methods and apparatus for renal neuromodulation
US9636174B2 (en) 2002-04-08 2017-05-02 Medtronic Ardian Luxembourg S.A.R.L. Methods for therapeutic renal neuromodulation
US20070129761A1 (en) 2002-04-08 2007-06-07 Ardian, Inc. Methods for treating heart arrhythmia
US8131371B2 (en) 2002-04-08 2012-03-06 Ardian, Inc. Methods and apparatus for monopolar renal neuromodulation
US7617005B2 (en) 2002-04-08 2009-11-10 Ardian, Inc. Methods and apparatus for thermally-induced renal neuromodulation
US8175711B2 (en) 2002-04-08 2012-05-08 Ardian, Inc. Methods for treating a condition or disease associated with cardio-renal function
US8774922B2 (en) 2002-04-08 2014-07-08 Medtronic Ardian Luxembourg S.A.R.L. Catheter apparatuses having expandable balloons for renal neuromodulation and associated systems and methods
US20080213331A1 (en) 2002-04-08 2008-09-04 Ardian, Inc. Methods and devices for renal nerve blocking
US7853333B2 (en) 2002-04-08 2010-12-14 Ardian, Inc. Methods and apparatus for multi-vessel renal neuromodulation
US9308043B2 (en) 2002-04-08 2016-04-12 Medtronic Ardian Luxembourg S.A.R.L. Methods for monopolar renal neuromodulation
US20040082859A1 (en) 2002-07-01 2004-04-29 Alan Schaer Method and apparatus employing ultrasound energy to treat body sphincters
US20070083240A1 (en) * 2003-05-08 2007-04-12 Peterson David K L Methods and systems for applying stimulation and sensing one or more indicators of cardiac activity with an implantable stimulator
US7162304B1 (en) * 2003-05-08 2007-01-09 Advanced Bionics Corporation System for measuring cardiac rhythm parameters for assessment of spinal cord stimulation
AU2003904303A0 (en) * 2003-08-12 2003-08-28 National Ageing Research Institute Incorporated Nerve function and tissue healing
US7480532B2 (en) 2003-10-22 2009-01-20 Cvrx, Inc. Baroreflex activation for pain control, sedation and sleep
US7775087B2 (en) * 2004-03-16 2010-08-17 Northwestern University Microchannel forming method and nanotipped dispensing device having a microchannel
US8082038B2 (en) * 2004-07-09 2011-12-20 Ebi, Llc Method for treating degenerative disc disease using noninvasive capacitively coupled electrical stimulation device
US7623924B2 (en) * 2004-08-31 2009-11-24 Leptos Biomedical, Inc. Devices and methods for gynecologic hormone modulation in mammals
US20120277839A1 (en) * 2004-09-08 2012-11-01 Kramer Jeffery M Selective stimulation to modulate the sympathetic nervous system
JP5132310B2 (en) 2004-09-08 2013-01-30 スパイナル・モデュレーション・インコーポレイテッド Neural stimulation method and system
US9205261B2 (en) 2004-09-08 2015-12-08 The Board Of Trustees Of The Leland Stanford Junior University Neurostimulation methods and systems
ATE439162T1 (en) * 2004-09-10 2009-08-15 Power Of Grace Pty Ltd DEVICE FOR TREATING DIABETES IN A MAMMAL
WO2006031899A2 (en) * 2004-09-10 2006-03-23 The Cleveland Clinic Foundation Intraluminal electrode assembly
US8676326B1 (en) * 2004-10-21 2014-03-18 Pacesetter, Inc Implantable device with responsive vascular and cardiac controllers
US7937143B2 (en) 2004-11-02 2011-05-03 Ardian, Inc. Methods and apparatus for inducing controlled renal neuromodulation
US7519431B2 (en) * 2005-04-11 2009-04-14 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
WO2006110206A1 (en) * 2005-04-11 2006-10-19 Medtronic, Inc. Shifting between electrode combinations in electrical stimulation device
US9592136B2 (en) 2005-07-25 2017-03-14 Vascular Dynamics, Inc. Devices and methods for control of blood pressure
US9125732B2 (en) 2005-07-25 2015-09-08 Vascular Dynamics, Inc. Devices and methods for control of blood pressure
US8862243B2 (en) * 2005-07-25 2014-10-14 Rainbow Medical Ltd. Electrical stimulation of blood vessels
US8923972B2 (en) 2005-07-25 2014-12-30 Vascular Dynamics, Inc. Elliptical element for blood pressure reduction
US9642726B2 (en) 2005-07-25 2017-05-09 Vascular Dynamics, Inc. Devices and methods for control of blood pressure
US8109879B2 (en) 2006-01-10 2012-02-07 Cardiac Pacemakers, Inc. Assessing autonomic activity using baroreflex analysis
US8295926B2 (en) 2006-06-02 2012-10-23 Advanced Neuromodulation Systems, Inc. Dynamic nerve stimulation in combination with other eating disorder treatment modalities
EP2106275A2 (en) * 2006-06-09 2009-10-07 Leptos Biomedical, Inc. Dynamic nerve stimulation employing frequency modulation
WO2008070808A2 (en) * 2006-12-06 2008-06-12 Spinal Modulation, Inc. Expandable stimulation leads and methods of use
US9314618B2 (en) 2006-12-06 2016-04-19 Spinal Modulation, Inc. Implantable flexible circuit leads and methods of use
EP2099374A4 (en) 2006-12-06 2012-10-03 Spinal Modulation Inc Hard tissue anchors and delivery devices
WO2008070807A2 (en) 2006-12-06 2008-06-12 Spinal Modulation, Inc. Delivery devices, systems and methods for stimulating nerve tissue on multiple spinal levels
JP5562648B2 (en) * 2007-01-29 2014-07-30 スパイナル・モデュレーション・インコーポレイテッド Non-stitched top retaining mechanism
US8249705B1 (en) 2007-03-20 2012-08-21 Cvrx, Inc. Devices, systems, and methods for improving left ventricular structure and function using baroreflex activation therapy
US8594794B2 (en) 2007-07-24 2013-11-26 Cvrx, Inc. Baroreflex activation therapy with incrementally changing intensity
US20090118777A1 (en) * 2007-08-09 2009-05-07 Kobi Iki Efferent and afferent splanchnic nerve stimulation
US8731665B1 (en) 2007-10-24 2014-05-20 Pacesetter, Inc. Posture detection using pressure and other physiologic sensors
US9005106B2 (en) * 2008-01-31 2015-04-14 Enopace Biomedical Ltd Intra-aortic electrical counterpulsation
US8626299B2 (en) 2008-01-31 2014-01-07 Enopace Biomedical Ltd. Thoracic aorta and vagus nerve stimulation
US8538535B2 (en) 2010-08-05 2013-09-17 Rainbow Medical Ltd. Enhancing perfusion by contraction
US8626290B2 (en) 2008-01-31 2014-01-07 Enopace Biomedical Ltd. Acute myocardial infarction treatment by electrical stimulation of the thoracic aorta
US8473062B2 (en) 2008-05-01 2013-06-25 Autonomic Technologies, Inc. Method and device for the treatment of headache
ES2725524T3 (en) 2008-09-26 2019-09-24 Vascular Dynamics Inc Devices and methods to control blood pressure
EP2373378B1 (en) 2008-10-27 2017-04-26 Spinal Modulation Inc. Selective stimulation systems and signal parameters for medical conditions
AU2008246284A1 (en) * 2008-11-19 2010-06-10 Zao, Ritm Okb Method for electrical influance on a living organism and device thereof
US8412336B2 (en) 2008-12-29 2013-04-02 Autonomic Technologies, Inc. Integrated delivery and visualization tool for a neuromodulation system
US8652129B2 (en) 2008-12-31 2014-02-18 Medtronic Ardian Luxembourg S.A.R.L. Apparatus, systems, and methods for achieving intravascular, thermally-induced renal neuromodulation
US8974445B2 (en) 2009-01-09 2015-03-10 Recor Medical, Inc. Methods and apparatus for treatment of cardiac valve insufficiency
US9320908B2 (en) 2009-01-15 2016-04-26 Autonomic Technologies, Inc. Approval per use implanted neurostimulator
US8494641B2 (en) 2009-04-22 2013-07-23 Autonomic Technologies, Inc. Implantable neurostimulator with integral hermetic electronic enclosure, circuit substrate, monolithic feed-through, lead assembly and anchoring mechanism
EP2411091A4 (en) 2009-03-24 2012-09-12 Spinal Modulation Inc Pain management with stimulation subthreshold to paresthesia
US8321030B2 (en) 2009-04-20 2012-11-27 Advanced Neuromodulation Systems, Inc. Esophageal activity modulated obesity therapy
US8340772B2 (en) 2009-05-08 2012-12-25 Advanced Neuromodulation Systems, Inc. Brown adipose tissue utilization through neuromodulation
US9259569B2 (en) * 2009-05-15 2016-02-16 Daniel M. Brounstein Methods, systems and devices for neuromodulating spinal anatomy
JP6231384B2 (en) 2010-05-10 2017-11-15 スパイナル・モデュレーション・インコーポレイテッドSpinal Modulation Inc. Method, system and device for suppressing misalignment
CN107007348B (en) 2010-10-25 2019-05-31 美敦力Af卢森堡有限责任公司 For the estimation of nerve modulation treatment and device, the system and method for feedback
US8649863B2 (en) 2010-12-20 2014-02-11 Rainbow Medical Ltd. Pacemaker with no production
AU2012212150B2 (en) 2011-02-02 2016-09-29 Spinal Modulation, Inc Devices, systems and methods for the targeted treatment of movement disorders
US8855783B2 (en) 2011-09-09 2014-10-07 Enopace Biomedical Ltd. Detector-based arterial stimulation
WO2013035092A2 (en) 2011-09-09 2013-03-14 Enopace Biomedical Ltd. Wireless endovascular stent-based electrodes
US9386991B2 (en) 2012-02-02 2016-07-12 Rainbow Medical Ltd. Pressure-enhanced blood flow treatment
AU2013230781B2 (en) 2012-03-08 2015-12-03 Medtronic Af Luxembourg S.A.R.L. Ovarian neuromodulation and associated systems and methods
RU2644933C2 (en) 2012-03-08 2018-02-14 Медтроник Аф Люксембург Сарл Biomarker samples selection as part of devices for neuromodulation and relevant systems and methods
US20140110296A1 (en) 2012-10-19 2014-04-24 Medtronic Ardian Luxembourg S.A.R.L. Packaging for Catheter Treatment Devices and Associated Devices, Systems, and Methods
WO2015068167A2 (en) 2013-11-06 2015-05-14 Enopace Biomedical Ltd. Wireless endovascular stent-based electrodes
US10194980B1 (en) 2014-03-28 2019-02-05 Medtronic Ardian Luxembourg S.A.R.L. Methods for catheter-based renal neuromodulation
US9980766B1 (en) 2014-03-28 2018-05-29 Medtronic Ardian Luxembourg S.A.R.L. Methods and systems for renal neuromodulation
US10194979B1 (en) 2014-03-28 2019-02-05 Medtronic Ardian Luxembourg S.A.R.L. Methods for catheter-based renal neuromodulation
US10376308B2 (en) 2015-02-05 2019-08-13 Axon Therapies, Inc. Devices and methods for treatment of heart failure by splanchnic nerve ablation
US9956393B2 (en) 2015-02-24 2018-05-01 Elira, Inc. Systems for increasing a delay in the gastric emptying time for a patient using a transcutaneous electro-dermal patch
US10376145B2 (en) 2015-02-24 2019-08-13 Elira, Inc. Systems and methods for enabling a patient to achieve a weight loss objective using an electrical dermal patch
US10335302B2 (en) 2015-02-24 2019-07-02 Elira, Inc. Systems and methods for using transcutaneous electrical stimulation to enable dietary interventions
US10765863B2 (en) 2015-02-24 2020-09-08 Elira, Inc. Systems and methods for using a transcutaneous electrical stimulation device to deliver titrated therapy
US10864367B2 (en) 2015-02-24 2020-12-15 Elira, Inc. Methods for using an electrical dermal patch in a manner that reduces adverse patient reactions
WO2016138176A1 (en) 2015-02-24 2016-09-01 Elira Therapeutics Llc Systems and methods for enabling appetite modulation and/or improving dietary compliance using an electro-dermal patch
US10207110B1 (en) 2015-10-13 2019-02-19 Axon Therapies, Inc. Devices and methods for treatment of heart failure via electrical modulation of a splanchnic nerve
CA3031766A1 (en) 2016-07-29 2018-02-01 Howard Levin Devices, systems, and methods for treatment of heart failure by splanchnic nerve ablation
US10561461B2 (en) 2017-12-17 2020-02-18 Axon Therapies, Inc. Methods and devices for endovascular ablation of a splanchnic nerve
CA3089217A1 (en) 2018-01-26 2019-08-01 Dorin Panescu Methods and devices for endovascular ablation of a splanchnic nerve
EP3917426B1 (en) 2019-06-20 2023-09-06 Axon Therapies, Inc. Devices for endovascular ablation of a splanchnic nerve
JP2023510597A (en) 2020-01-17 2023-03-14 アクソン セラピーズ,インク. Method and device for endovascular ablation of visceral nerves
US11400299B1 (en) 2021-09-14 2022-08-02 Rainbow Medical Ltd. Flexible antenna for stimulator

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE346468B (en) * 1969-02-24 1972-07-10 Lkb Medical Ab
US4453547A (en) * 1981-04-06 1984-06-12 Physio Technology, Inc. T-Wave inhibiting system
GB8406509D0 (en) * 1984-03-13 1984-04-18 Bio Medical Res Ltd Electrical stimulation of muscle
US4974599A (en) * 1988-10-25 1990-12-04 Sharp Kabushiki Kaisha Portable electrocardiograph
US5056519A (en) * 1990-05-14 1991-10-15 Vince Dennis J Unilateral diaphragmatic pacer
US5058584A (en) * 1990-08-30 1991-10-22 Medtronic, Inc. Method and apparatus for epidural burst stimulation for angina pectoris
US5146918A (en) * 1991-03-19 1992-09-15 Medtronic, Inc. Demand apnea control of central and obstructive sleep apnea

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
No further relevant documents disclosed *
See also references of WO9517921A1 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006079484A1 (en) 2005-01-26 2006-08-03 Cerbomed Gmbh Device for the transdermal stimulation of a nerve of the human body
DE102011009528A1 (en) 2011-01-26 2012-07-26 Cerbomed Gmbh Device for transcutaneous stimulation of a nerve of the human body
WO2012100913A1 (en) 2011-01-26 2012-08-02 Cerbomed Gmbh Device for arranging on or in an ear for transcutaneous stimulation of a nerve

Also Published As

Publication number Publication date
DE69434666T2 (en) 2007-02-01
WO1995017921A1 (en) 1995-07-06
EP0757573A4 (en) 1997-03-26
DE69434666D1 (en) 2006-05-11
AU1866795A (en) 1995-07-17
US5458626A (en) 1995-10-17
EP0757573B1 (en) 2006-03-15

Similar Documents

Publication Publication Date Title
US5458626A (en) Method of electrical nerve stimulation for acceleration of tissue healing
Campbell et al. Peripheral nerve stimulation in the treatment of intractable pain
US5358513A (en) Parameter selection and electrode placement of neuromuscular electrical stimulation apparatus
RU2291723C2 (en) Method and device for treating living organism to reduce heart load
US8868204B2 (en) Esthetic device useful for increasing skin beautification and methods thereof
JP4401057B2 (en) Electrical stimulation system for wound treatment
Mercola et al. The basis for microcurrent electrical therapy in conventional medical practice
BORST et al. Optimal frequency of carotid sinus nerve stimulation in treatment of angina pectoris
KR20040071166A (en) Device and method to modulate blood pressure by electrical waveforms
Gorodnichev et al. Transcutaneous electrical stimulation of the spinal cord: A noninvasive tool for the activation of stepping pattern generators in humans
JP2007535978A (en) Electromagnetic induction processing apparatus and method
AU2008326528A1 (en) System and method for generating complex bioelectric stimulation signals while conserving power
RU2002107014A (en) METHOD FOR TREATING A LIVING ORGANISM FOR REDUCING THE LOAD OF THE HEART AND A DEVICE FOR IMPLEMENTING THIS METHOD
US20020120309A1 (en) System and method for providing recovery from muscle denervation
US20020183659A1 (en) Method and apparatus for promoting the healing of human tissue
Peters et al. Search for optimal frequencies and amplitudes of therapeutic electrical carotid sinus nerve stimulation by application of the evolution strategy
Lau et al. Fatigue reduction by sequential stimulation of multiple motor points in a muscle.
US20030220672A1 (en) Muscle stimulation in a cast-immobilized limb
RU2412728C2 (en) Method of treating and rehabilitation of patients with severe injuries of radial nerve
CN110840736A (en) Paralytic limb movement function reconstruction system adopting electric needle and electric moxibustion medical technology
Shealy et al. Modern medical electricity in the management of pain
EP1694404A1 (en) Electrotherapy apparatus and method of treating a person or a mammal using such electrotherapy apparatus
RU2122394C1 (en) Method for curing paralysis and paresis decease
RU2045286C1 (en) Method of electrotherapy and device for carrying out same
SU1146061A1 (en) Method of restoring the function of injured peripheric nerve

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19960817

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): DE FR GB IT NL

A4 Supplementary search report drawn up and despatched

Effective date: 19970210

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): DE FR GB IT NL

17Q First examination report despatched

Effective date: 20010629

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

RTI1 Title (correction)

Free format text: APPARATUS FOR ELECTRICAL NERVE STIMULATION

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): DE FR GB IT NL

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 69434666

Country of ref document: DE

Date of ref document: 20060511

Kind code of ref document: P

ET Fr: translation filed
PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20061218

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20131219

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20131223

Year of fee payment: 20

Ref country code: NL

Payment date: 20131219

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20140117

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20131220

Year of fee payment: 20

REG Reference to a national code

Ref country code: DE

Ref legal event code: R071

Ref document number: 69434666

Country of ref document: DE

REG Reference to a national code

Ref country code: NL

Ref legal event code: V4

Effective date: 20141227

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20141226

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20141226